Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.
about
Gene Therapy for Cardiovascular DiseaseImproved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vectorPhotodynamic therapy induces apoptosis in intimal hyperplastic arteries.c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis.Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis.The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies.Gene therapy for vein graft disease.Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease.Post-intervention vessel remodeling.Matrix metalloproteinases and coronary artery diseases.Gene therapy for all aspects of vein-graft disease.The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis.Temporal regulation of venous extracellular matrix components during arteriovenous fistula maturation.Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene TherapyCardiovascular gene delivery: The good road is awaitingMatrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Gene therapy for the extension of vein graft patency: a review.Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3).Accelerated apoptosis in the Timp-3-deficient mammary gland.Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations.Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice.Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery.Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.In vivo modulation of Nogo-B attenuates neointima formation.Vascular access thrombosis prophylaxis.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.Gene therapy for the prevention of vein graft diseaseDelivery of large biopharmaceuticals from cardiovascular stents: a reviewMARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein.Coronary vein graft disease: pathogenesis and prevention.Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.Vein graft failure: current clinical practice and potential for gene therapeutics.Glucocorticoids in adult cardiac surgery; old drugs revisited.Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening.Vein graft failure: from pathophysiology to clinical outcomes.Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector.
P2860
Q24791063-B2EC51E6-F8E6-4DD4-8E9A-44ABA3520ACEQ24804662-F5562931-8522-4DE6-B000-2DA0BA9976AAQ31807503-28B8C972-2988-498F-A917-0B211BFB811EQ33662275-042FAA3D-A749-4C6C-A0A8-564A48BF6A87Q33906860-3EB015D1-C441-49E7-8CEE-58D7CFCF049BQ34074837-576ADFC3-2987-4434-8C32-13AE88931249Q34107537-646B42F6-4DBE-417E-BC9C-D4545D96CFDBQ34119443-E232F36E-7A3A-4AF1-806F-DC01A3634978Q34347211-BCC694C3-BDF8-4F10-8F31-D01A9EB612CAQ34983850-DE18D16F-FFCF-4429-B678-79401C5E988CQ35081023-D600F9AE-0A96-4860-A508-EC9FC02C2E2EQ35087837-429ACE8E-1689-4FFC-9545-34A6BA4F8ED8Q35170453-D400A14E-ECA8-468B-809D-A303B0B94978Q35508544-98337D33-4D20-4867-9176-AF99EA3CE6ECQ35733486-81633B22-9491-4D10-BBBE-684970246463Q35913519-0F865E9B-9AD1-4053-BA47-3ECB57294E8EQ35915765-BF14A71B-6CD7-4B8E-AEEA-B549A2E0B2F5Q36009930-3C51EA70-5117-436C-8EE7-E909086A94F6Q36032833-613E0810-C156-4A3A-B360-B37B0D96B053Q36041136-2A5EBB20-F808-481B-9E89-FF32FED7728BQ36041423-E7BB2373-6B3B-44B0-8B9E-F30221042D30Q36310750-B67E6DE5-3777-4866-A974-6656ED8AD120Q36311525-37097A60-8689-427C-888E-762E20AFFFF4Q36382691-90AD8724-80D1-44FD-890D-C00521EBFAC2Q36469473-D40B4000-FC54-49C6-8A6F-B71DF86706D4Q36531448-38FE5E54-1FE8-4C66-AA72-90DCD2E9C081Q36558741-555BB3AC-F2DE-4B91-A0E8-49334F2EF9BEQ36644577-4B55B620-5A68-4E90-837D-43665D9EFF3EQ36690251-A012B38D-BB42-408F-951C-A055D005B3BFQ36698258-BF7B6CA3-5294-47CC-A4D9-DC4609E8C1C2Q36968009-26C1EEF1-8176-4A4B-9CB7-B96C1F349612Q37072403-EC159466-B76F-47FC-BF50-C824B84DDBC0Q37215596-4FD44EFB-8EDF-4A00-A3E8-28E6C4BD2DE5Q37406279-55139736-1AA3-433B-B750-8B71931437B3Q37997898-65B5D049-4044-4096-A4CB-AB580052D9A5Q38110419-3A7D8A50-D956-45BE-8D98-166E3B52F055Q38220601-DC4BE147-9CB0-47A9-ABA4-4161CCC96B8FQ38358592-2E769F99-2B98-4952-A24D-1B45B7D4202AQ38837879-A0542EA2-6AD3-42B8-928C-4D8CA7E1D983Q38901143-0100B1E4-4A8E-46F0-B9DD-B9FC0A17B5D2
P2860
Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@en
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@nl
type
label
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@en
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@nl
prefLabel
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@en
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@nl
P2093
P356
P1433
P1476
Inhibition of late vein graft ...... ibitor of metalloproteinase-3.
@en
P2093
P304
P356
10.1161/01.CIR.101.3.296
P407
P577
2000-01-01T00:00:00Z